Document Detail


Effectiveness factor and diffusion limitations in collagen gel modules containing HepG2 cells.
MedLine Citation:
PMID:  20653045     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
A major obstacle in tissue engineering is overcoming hypoxia in thick, three-dimensional (3D) engineered tissues, which is caused by the diffusional limitations of oxygen and lack of internal vasculature to facilitate mass transfer. Modular tissue engineering is a bio-mimetic strategy that forms scalable, vascularized and uniform 3D constructs by assembling small (sub-mm), cell-containing modules. It was previously assumed that mass transfer resistance within the individual modules was negligible, due to their small size. In the present study, this assumption was tested using theoretical analysis of oxygen transport within the module (effectiveness factor) and experimental studies. Small (400 µm diameter post-contraction) and large (700 µm diameter post-contraction) HepG2-collagen modules were made for a range of seeding densities (2 × 10(6) -1 × 10(7) cells/ml collagen). Cell density, distribution and morphology within the modules showed that the small modules were capable of sustaining high cell densities (8.0 × 10(7) ± 4.4 × 10(7) cells/cm(3) ) with negligible mass transfer inhibition. Conversely, large modules developed a necrotic core and had significantly (p < 0.05) reduced cell densities (1.5 × 10(7) ± 9.2 × 10(6) cells/cm(3) ). It was also observed that the embedded cells responded quickly to the oxygen availability, by proliferating or dying, to reach a sustainable density of approximately 8000 cells/module. Furthermore, a simple effectiveness factor calculation was successful in estimating the maximum cell density per module. The results gathered in this study confirm the previous assumption that the small-diameter modules avoid the internal mass transfer limitations that are often observed in larger constructs.
Authors:
Lindsay Corstorphine; Michael V Sefton
Related Documents :
6191515 - A tissue model for quantitative studies on time course of healing, rate of healing, and...
18036685 - Nanotechnology in regenerative medicine: the materials side.
19963015 - Direct effects of casein phosphopeptides on growth and differentiation of in vitro cult...
15095815 - Crosslinking density influences chondrocyte metabolism in dynamically loaded photocross...
21140155 - Effects of seasonality and moult cycle on the proliferation of nerve cells and on the l...
24841295 - Basic investigations in saccharomyces cerevisiae.
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Journal of tissue engineering and regenerative medicine     Volume:  5     ISSN:  1932-7005     ISO Abbreviation:  J Tissue Eng Regen Med     Publication Date:  2011 Feb 
Date Detail:
Created Date:  2011-01-26     Completed Date:  2011-04-25     Revised Date:  2013-05-29    
Medline Journal Info:
Nlm Unique ID:  101308490     Medline TA:  J Tissue Eng Regen Med     Country:  England    
Other Details:
Languages:  eng     Pagination:  119-29     Citation Subset:  IM    
Copyright Information:
Copyright © 2010 John Wiley & Sons, Ltd.
Affiliation:
Institute of Biomaterials and Biomedical Engineering, University of Toronto, Canada.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Cell Hypoxia
Collagen*
Gels
Hep G2 Cells
Humans
Tissue Engineering / methods*
Tissue Scaffolds*
Grant Support
ID/Acronym/Agency:
EB 006903/EB/NIBIB NIH HHS; R01 EB006903-03/EB/NIBIB NIH HHS
Chemical
Reg. No./Substance:
0/Gels; 9007-34-5/Collagen
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Impact of pre-existing elastic matrix on TGF?1 and HA oligomer-induced regenerative elastin repair b...
Next Document:  Cathepsin B contributes to traumatic brain injury-induced cell death through a mitochondria-mediated...